Long-term Puberty Suppression for a Nonbinary Teenager.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 31974217.
- Also identified by DOI 10.1542/peds.2019-1606.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Many transgender and gender-diverse people have a gender identity that does not conform to the binary categories of male or female; they have a nonbinary gender. Some nonbinary individuals are most comfortable with an androgynous gender expression. For those who have not yet fully progressed through puberty, puberty suppression with gonadotrophin-releasing hormone agonists can support an androgynous appearance. Although such treatment is shown to ameliorate the gender dysphoria and serious mental health issues commonly seen in transgender and gender-diverse young people, long-term use of puberty-suppressing medications carries physical health risks and raises various ethical dilemmas. In this Ethics Rounds, we analyze a case that raised issues about prolonged pubertal suppression for a patient with a nonbinary gender.
Medical subject headings
- Gender Dysphoria
- Informed Consent By Minors
- Parental Consent
- Puberty
- Selective Estrogen Receptor Modulators
- Sexual and Gender Minorities